Available for both iPad & iPhone, the new and improved The Lancet app is free to download and offers current subscribers rapid access to recently published content from The Lancet and our specialty publications: The Lancet Oncology, The Lancet Neurology, The Lancet Infectious Diseases, The Lancet Diabetes & Endocrinology, The Lancet Global Health, The Lancet Respiratory Medicine, The Lancet Psychiatry, The Lancet HIV, The Lancet Haematology, The Lancet Gastroenterology & Hepatology, The Lancet Public Health, The Lancet Planetary Health, The Lancet Child & Adolescent Health, EBioMedicine, and EClinicalMedicine journals.
The Lancet publishes a weekly journal and nine monthly specialty journals in the fields of global health, diabetes and endocrinology, oncology, neurology, psychiatry, respiratory medicine, haematology, HIV, and infectious diseases.
Your iTunes account will automatically be charged the same price for the renewal within 24 hours prior to the end of the current period unless you change your subscription preferences in your iTunes Account Settings.
Journal subscribers: Log in with the same username and password that grants you access to the full journal content on the journal website.
• Experience innovative digital content with the newly introduced Article enhancements; featuring AudioSlides, Virtual Microscope, 3D Radiological Viewer, 3D Neuroimaging Viewer, and more.
The app brings the world’s leading independent medical journal and its specialty titles to your fingertips.
Payment for all purchases will be charged to your iTunes account upon confirmation of purchase.
You can cancel at any time and up to 24 hours before your current subscription expires.
No cancellation of the current subscription is allowed during the active subscription period.
These credentials will allow full access to all content on the app.
Yearly iTunes subscriptions will automatically renew each year unless you cancel.
You can manage your subscriptions through your Account Settings after purchase.
Subscription Fees Vary by title.